Narine Wandrey
YOU?
Author Swipe
View article: Ablative Preoperative Single-Fraction Radiation Dose Escalation Among Patients With Breast Cancer
Ablative Preoperative Single-Fraction Radiation Dose Escalation Among Patients With Breast Cancer Open
Importance Single-fraction preoperative ablative stereotactic partial breast irradiation (sPBI) can be safely delivered in early-stage hormone receptor–positive (HR + ) breast cancer with delayed time to surgery and high pathologic complet…
View article: P11.14.A STEREOTACTIC RADIOSURGERY FOR OVARIAN CANCER BRAIN METASTASES: AN INTERNATIONAL RADIOSURGERY RESEARCH FOUNDATION RETROSPECTIVE STUDY
P11.14.A STEREOTACTIC RADIOSURGERY FOR OVARIAN CANCER BRAIN METASTASES: AN INTERNATIONAL RADIOSURGERY RESEARCH FOUNDATION RETROSPECTIVE STUDY Open
BACKGROUND Ovarian cancer rarely metastasises to the brain, thus studies reporting the outcomes of affected patients are lacking. Stereotactic radiosurgery (SRS) is now the mainstay of management for patients with brain metastases (BM) fro…
View article: Assessment of cardiac radiation dose in the Co-60 prone-based stereotactic partial breast irradiation using distance metrics
Assessment of cardiac radiation dose in the Co-60 prone-based stereotactic partial breast irradiation using distance metrics Open
Purpose/objective(s) The GammaPod™ (GP) system, a contemporary platform dedicated to breast cancer (BC) radiotherapy, facilitates the delivery of accelerated partial breast irradiation (APBI) via the Co-60 prone-based stereotactic partial …
View article: Radiation Recall Phenomenon Following Vaccination in a Patient With Prior Radiation to Lower Extremity Liposarcoma
Radiation Recall Phenomenon Following Vaccination in a Patient With Prior Radiation to Lower Extremity Liposarcoma Open
View article: P175: Can time to surgery or size of tumor predict pathologic complete response (pCR) for early stage hormone receptor positive (HR+) (HER2-) breast cancer on a preoperative ablative S-PBI phase I trial
P175: Can time to surgery or size of tumor predict pathologic complete response (pCR) for early stage hormone receptor positive (HR+) (HER2-) breast cancer on a preoperative ablative S-PBI phase I trial Open
View article: CP-10. DOES PRE-IRRADIATION GROSS TUMOR VOLUME PREDICT THE RISK OF PROGRESSION AFTER RADIATION THERAPY IN PEDIATRIC PATIENTS WITH ADAMANTINOMATOUS CRANIOPHARYNGIOMA?
CP-10. DOES PRE-IRRADIATION GROSS TUMOR VOLUME PREDICT THE RISK OF PROGRESSION AFTER RADIATION THERAPY IN PEDIATRIC PATIENTS WITH ADAMANTINOMATOUS CRANIOPHARYNGIOMA? Open
OBJECTIVE In a cohort of patients who were treated with resection and adjuvant radiotherapy (RT) for adamantinomatous craniopharyngioma (ACP), we explored whether gross tumor volume (GTV) at the initiation of RT was associated with the ris…
View article: Multimodal radiotherapy dose prediction using a multi‐task deep learning model
Multimodal radiotherapy dose prediction using a multi‐task deep learning model Open
Background In radiation therapy (RT), accelerated partial breast irradiation (APBI) has emerged as an increasingly preferred treatment modality over conventional whole breast irradiation due to its targeted dose delivery and shorter course…
View article: Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)
Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE) Open
Introduction Historical reservations regarding stereotactic radiosurgery (SRS) for small-cell lung cancer (SCLC) brain metastases include concerns for short-interval and diffuse central nervous system (CNS) progression, poor prognoses, and…
View article: Multimodality Management of EBV-Associated Nasopharyngeal Carcinoma
Multimodality Management of EBV-Associated Nasopharyngeal Carcinoma Open
Nasopharyngeal carcinoma (NPC) is a rare cancer of the nasopharyngeal mucosa with a specific geographic predisposition. NPC is often associated with Epstein–Barr Virus (EBV) infection and as a result contains many characteristic biomarkers…
View article: Dramatic Resolution of an Unresectable Giant Basal Cell Carcinoma Treated with Intensity-Modulated Radiation Therapy (IMRT) - A Case Report
Dramatic Resolution of an Unresectable Giant Basal Cell Carcinoma Treated with Intensity-Modulated Radiation Therapy (IMRT) - A Case Report Open
A 59-year-old man presented with an unresectable bulky giant basal cell carcinoma on his upper back. A trial of chemotherapy did not help relieve his symptoms or reduce the tumor. He was referred for and received definitive radiation thera…